Search Results - Vimal H. Prajapati

Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis by Lyn Guenther, Irina Turchin, Ron Vender, Lorne E. Albrecht, Catherine Maari, Howard Yanofsky, Vimal H. Prajapati

Connect to this object online.

The burden of palmoplantar pustulosis: A Canadian population-based study of inpatient care, emergency departments, and outpatient clinicsCapsule Summary by Jean-Eric Tarride, MA, PhD, Vimal H. Prajapati, MD, Charles Lynde, MD, Gord Blackhouse, MA, MBA

Connect to this object online.

The burden associated with generalized pustular psoriasis: A Canadian population-based study of inpatient care, emergency departments, and hospital- or community-based outpatient c... by Jean-Eric Tarride, MA, PhD, Vimal H. Prajapati, MD, Charles Lynde, MD, Gord Blackhouse, MA, MBA

Connect to this object online.

Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors by Mark G. Kirchhof, Vimal H. Prajapati, Melinda Gooderham, Chih-ho Hong, Charles W. Lynde, Catherine Maari, Irina Turchin, Kim A. Papp

Connect to this object online.

Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based review by Abrahim Abduelmula, BScN, Asfandyar Mufti, MD, Derrick H.Y. Chong, BSc, Siddhartha Sood, HBSc, Vimal H. Prajapati, MD, Jensen Yeung, MD

Connect to this object online.

Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective ch... by Ronald Vender, MD, Irina Turchin, MD, Perla Lansang, MD, Vimal H. Prajapati, MD, Mark Legault, PhD, Maxime Barakat, MD, PhD, MBA, Jensen Yeung, MD

Connect to this object online.

Methotrexate-induced cutaneous ulceration and necrosis in chronic atopic dermatitis by Malika A. Ladha, MD, Bryn Edgerton, BSc (Hons), Jonathan Levy, MD, Muhammad N. Mahmood, MD, Alim R. Devani, MD, Parbeer S. Grewal, MD, Vimal H. Prajapati, MD

Connect to this object online.

Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review by Siddhartha Sood, HBSc, Ahmed Bagit, BSc, Martin Heung, Khalad Maliyar, MD, Abrahim Abduelmula, MD, Muskaan Sachdeva, MD, Jorge R. Georgakopoulos, MD, Asfandyar Mufti, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD

Connect to this object online.

Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the... by Ahmed Bagit, BSc, Khalad Maliyar, MD, Jorge R. Georgakopoulos, MD, Brian Rankin, BSc, Alexander Rimke, MSc, Asfandyar Mufti, MD, Heather Le, CRC, Ronald Vender, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD

Connect to this object online.

Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study by Yuliya Lytvyn, PhD, Asfandyar Mufti, MD, Hiba Zaaroura, MD, Muskaan Sachdeva, BHSc, Justin D. Lu, MSc, Brian D. Rankin, PhD, Vimal H. Prajapati, MD, Ronald Vender, MD, Jensen Yeung, MD, FRCPC

Connect to this object online.

Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel by Kim A. Papp, Barbara Melosky, Sandeep Sehdev, Sebastien J. Hotte, Jennifer R. Beecker, Mark G. Kirchhof, Irina Turchin, Jan P. Dutz, Melinda J. Gooderham, Robert Gniadecki, Chih-ho Hong, Jo Lambert, Charles W. Lynde, Vimal H. Prajapati, Ronald B. Vender

Connect to this object online.

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Pa... by Kim A. Papp, Barbara Melosky, Sandeep Sehdev, Sebastien J. Hotte, Jennifer R. Beecker, Mark G. Kirchhof, Irina Turchin, Jan P. Dutz, Melinda J. Gooderham, Robert Gniadecki, Chih-ho Hong, Jo Lambert, Charles W. Lynde, Vimal H. Prajapati, Ronald B. Vender

Connect to this object online.

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2) by Eric L. Simpson, Vimal H. Prajapati, Yael A. Leshem, Raj Chovatiya, Marjolein S. de Bruin-Weller, Sonja Ständer, Andrew E. Pink, Brian M. Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M. Platt, Jonathan I. Silverberg

Connect to this object online.